Skip to main content

Search articles in Medical Devices

Found 28 articles

  • Stryker completes acquisition of Artelon, Inc.

    Stryker completes acquisition of Artelon, Inc.

    • 16 Jul 2024
    • Editor

    Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for foot and ankle and sports medicine procedures.

  • Danaher Launches Beacon Research Collaboration wit

    Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening

    • 12 Jul 2024
    • Editor

    Danaher Corporation (NYSE: DHR), a global science and technology innovator, today launched a research collaboration with Stanford University's Department of Bioengineering intended to shape the future of cancer drug screening through "smart microscopy."

  • Roche receives CE Mark for its AI-enabled continuo

    Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes

    • 9 Jul 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received the CE Mark for its Accu-Chek SmartGuide® continuous glucose monitoring (CGM) solution. This significant milestone paves the way for the solution to be made available to people living with type 1 and type 2 diabetes over the age of 18 on flexible insulin therapy.

  • Roche launches new highly-sensitive test to more e

    Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma

    • 20 Jun 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the first clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark.

  • Boston Scientific Announces Agreement to Acquire S

    Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc.

    • 19 Jun 2024
    • Editor

    Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).

  • ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD'S

    ABBOTT RECEIVES CE MARK FOR AVEIR™ DR, THE WORLD'S FIRST DUAL CHAMBER LEADLESS PACEMAKER SYSTEM

    • 7 Jun 2024
    • Editor

    Abbott today announced it has received CE Mark in Europe for the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacemaker that treats people with abnormal or slow heart rhythms. Approximately 49 million people are living with cardiovascular disease in the European Union, and it is estimated that 14.4 million people 65 and older will have atrial fibrillation by 2060.

  • Thermo Fisher Scientific Introduces Innovative Mas

    Thermo Fisher Scientific Introduces Innovative Mass Spectrometer to Advance Clinical Research

    • 4 Jun 2024
    • Editor

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled the Thermo Scientific™ Stellar™ mass spectrometer (MS), a new solution that combines fast throughput, high sensitivity, and ease of use to allow researchers to advance their translational omics research and make breakthrough discoveries more efficiently.

  • Roche granted FDA Breakthrough Device Designation

    Roche granted FDA Breakthrough Device Designation for blood test measuring Lp(a) – a key marker for hereditary cardiovascular risk

    • 22 May 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Tina-quant® lipoprotein Lp(a) RxDx assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) to identify patients who may benefit from innovative Lp(a)-lowering therapy currently in development.

  • Thermo Fisher Scientific Introduces Array-based So

    Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions

    • 16 May 2024
    • Editor

    Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Applied Biosystems™ Axiom™ BloodGenomiX™ Array* and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects most extended and rare blood groups, tissue (HLA) and platelet (HPA) types in a single, high-throughput assay, supporting future advancements in donor blood matching for extended phenotypes.

  • Breakthrough paves the way for next generation of

    Breakthrough paves the way for next generation of vision implants

    • 7 May 2024
    • Editor

    A group of researchers from Chalmers University of Technology in Sweden, University of Freiburg and the Netherlands Institute for Neuroscience have created an exceptionally small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the blind.

  • Thermo Fisher Scientific Launches New CXCL10 Testi

    Thermo Fisher Scientific Launches New CXCL10 Testing Service

    • 3 May 2024
    • Editor

    For organ transplant recipients, life post-transplant involves a delicate balance between invasive monitoring and immunosuppression to reduce the risk of rejection, both of which may carry complications. Now, a simple, urine-based assay that detects the CXCL10 chemokine may make care more convenient and less invasive for the nearly 250,000 Americans living with a kidney transplant.

  • Stryker completes acquisition of mfPHD

    Stryker completes acquisition of mfPHD

    • 2 May 2024
    • Editor

    Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of mfPHD, a leader in modular stainless steel wall systems for hospitals and ambulatory surgery centers.

  • ABBOTT'S BREAKTHROUGH DISSOLVING STENT RECEIVES FD

    ABBOTT'S BREAKTHROUGH DISSOLVING STENT RECEIVES FDA APPROVAL FOR ARTERIES BELOW THE KNEE

    • 30 Apr 2024
    • Editor

    Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

  • Labcorp Announces First-of-Its-Kind Test for Early

    Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw

    • 16 Apr 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the availability of the nation's first test for glial fibrillary acidic protein (GFAP), a critical blood-based biomarker for the early detection of neurodegenerative diseases and neurological injuries.

  • Roche granted FDA Breakthrough Device Designation

    Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis

    • 11 Apr 2024
    • Editor

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its Elecsys pTau217 assay received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

  • Labcorp Receives FDA Emergency Use Authorization f

    Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit

    • 11 Apr 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Mpox PCR Test Home Collection Kit to aid in the diagnosis of infection with non-variola Orthopoxvirus, including the monkeypox virus that causes monkeypox, also known as mpox.

  • Thermo Fisher Scientific Launches New ENERGY STAR

    Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times

    • 9 Apr 2024
    • Editor

    Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers.

  • Abbott Receives FDA Approval for TriClip™, First-o

    Abbott Receives FDA Approval for TriClip™, First-of-its-Kind Device to Repair Leaky Tricuspid Heart Valve

    • 3 Apr 2024
    • Editor

    Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip™ transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve.

  • Baxter Announces U.S. FDA Clearance of Novum IQ La

    Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

    • 2 Apr 2024
    • Editor

    Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software.

  • BiVACOR® Receives $13 Million to Support Clinical

    BiVACOR® Receives $13 Million to Support Clinical Trials for the Company’s Total Artificial Heart

    • 21 Feb 2024
    • Editor

    BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (MRFF) grant through the Artificial Heart Frontiers Program (AHFP) to support BiVACOR’s Total Artificial Heart program and future product enhancements.